DIRECT. Results of the study on effectiveness of candesartan (angiotensin II receptor antaginist) in prevention of diabetes retinopathy progression

DIRECT. Results of the study on effectiveness of candesartan (angiotensin II receptor antaginist) in prevention of diabetes retinopathy progression

Bibliographic Details
Main Author:	Editorial team Diabetes Mellitus
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2008-09-01
Series:	Сахарный диабет
Online Access:	https://www.dia-endojournals.ru/jour/article/view/5364

Similar Items

Cerebroprotective effects of angiotensin II receptor blockers: candesartan focus
by: O. D. Ostroumova, et al.
Published: (2018-09-01)

The effects of angiotensin II receptor antagonist (candesartan) on rat renal vascular resistance
by: Supatraviwat, J, et al.
Published: (2004-05-01)

The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics
Published: (2005-03-01)

Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT2- receptors
by: Stephen Phoon, et al.
Published: (2002-03-01)

Angiotensin II receptor blockers in the treatment of arterial hypertension in patients with concomitant pathology: focus on candesartan
by: D I Trukhan
Published: (2014-09-01)

The ACCORD-EYE study results
by: Editorial team Diabetes Mellitus
Published: (2010-06-01)

Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: role of angiotensin II type 2 receptor
by: Bodh I Jugdutt, et al.
Published: (2001-03-01)

Interview with professor I.I. Dedov
by: Editorial team Diabetes Mellitus
Published: (2011-03-01)

Abilities of candesartan and other AT receptor blockers to impair angiotensin II-induced AT receptor activation after wash-out
by: Yoshihiro Kiya, et al.
Published: (2012-03-01)

Differential clinical profile of candesartan compared to other angiotensin receptor blockers
by: Zimlichman R
Published: (2011-12-01)

I.I. Dedov (on the 60th anniversary)
by: Editorial team Diabetes Mellitus
Published: (2000-12-01)

The effects of candesartan on vascular responses to angiotensin II and norepinephrine in normal volunteers
by: Diane Tran, et al.
Published: (2001-09-01)

Results of ADVANCE stydy in type 2 diabetes patients
by: Editorial team Diabetes Mellitus
Published: (2007-09-01)

The DIabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design
by: Nish Chaturvedi
Published: (2002-12-01)

Results of the international forum "Joun together againts diabetes". Resolution project
by: Editorial team Diabetes Mellitus
Published: (2008-12-01)

Queen Margrette II of Denmark has visited Endocrinology Research Center
by: Editorial team Diabetes Mellitus
Published: (2011-09-01)

HYVET. Results of the randomized blinded placebo-controlled study on the effectiveness of arterial pressure lowerind in peoples upward 80 years
by: Editorial team Diabetes Mellitus
Published: (2008-09-01)

Effect of angiotensin II receptor blockers, candesartan, on osteoprotegerin level in hypertensive patients: Link between bone and RAAS
by: H Oz, et al.
Published: (2015-09-01)

Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory Activity
by: Wen-Yu Lin, et al.
Published: (2022-05-01)

ADVANCE: intensivу glucose control brings tower risk of severe diabetes complications. Results of the ADVANCE study goes beyond current evidence
by: Editorial team Diabetes Mellitus
Published: (2008-06-01)

Valsartan and candesartan can inhibit deteriorating effects of angiotensin II on coronary endothelial function
by: Harald Seeger, et al.
Published: (2001-06-01)

Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation
by: Jin Wook Lee, et al.
Published: (2023-05-01)

Candesartan inhibits inflammation through an angiotensin II type 1 receptor independent way in human embryonic kidney epithelial cells
by: YING YU, et al.
Published: (2019-04-01)

Reversible renal impairment induced by treatment with the angiotensin II receptor antagonist candesartan in a patient with bilateral renal artery stenosis
by: Kjaer Andreas, et al.
Published: (2001-05-01)

Prevention of atherosclerosis by specific AT1-receptor blockade with candesartan cilexetil
by: Vasilios Papademetriou, et al.
Published: (2001-03-01)

Candesartan cilexetil in cardiovascular prevention
by: A. Ya. Ivleva
Published: (2007-12-01)

Internalization of Constitutively Active N111G Mutant of AT1 Receptor Induced by Angiotensin II–Receptor Antagonists Candesartan, Losartan, and Telmisartan: Comparison With Valsartan
by: Mohiuddin Ahmed Bhuiyan, et al.
Published: (2010-01-01)

Guides for authors
by: Editorial team Diabetes Mellitus
Published: (2008-09-01)

Russian science conference "Diabetes and Kidney"
by: Editorial team Diabetes Mellitus
Published: (2008-09-01)

Abstracts of the best foregn articles
by: Editorial team Diabetes Mellitus
Published: (2005-03-01)

Report of the European department of WHO on medical care quality and technology level enrichment in 1996-1998
by: Editorial team Diabetes Mellitus
Published: (1999-06-01)

Professor S.A.Abusuev (on 60th anniversary)
by: Editorial team Diabetes Mellitus
Published: (2000-03-01)

Abstracts
by: Editorial team Diabetes Mellitus
Published: (1999-06-01)

Abstracts
by: Editorial team Diabetes Mellitus
Published: (2000-06-01)

Ildar G. Akmaev (on the 70th anniversary)
by: Editorial team Diabetes Mellitus
Published: (2000-06-01)

Foreign news
by: Editorial team Diabetes Mellitus
Published: (2005-12-01)

List of dissertations in the field of Endocrinology
by: Editorial team Diabetes Mellitus
Published: (2000-12-01)

Myth in diabetology
by: Editorial team Diabetes Mellitus
Published: (2003-09-01)

News form the 35th annual meeting of the European Association on Study of Diabetes
by: Editorial team Diabetes Mellitus
Published: (2000-03-01)

Abstracts of the best foreign studies
by: Editorial team Diabetes Mellitus
Published: (2005-06-01)